Bio-Reference Laboratories Inc. (BRLI)
-NasdaqGS 30.75 
0.46(1.47%) May 24, 4:00PM EDT|After Hours
:
31.21 0.46 (1.50%) May 24, 5:00PM EDT
| Prev Close: | 31.21 |
|---|
| Open: | 30.92 |
|---|
| Bid: | 29.57 x 500 |
|---|
| Ask: | 31.58 x 400 |
|---|
| 1y Target Est: | 32.50 |
|---|
| Beta: | 1.07 |
|---|
| Next Earnings Date: | 6-Jun-13 |
|---|
| Day's Range: | 30.48 - 31.36 |
|---|
| 52wk Range: | 18.29 - 32.86 |
|---|
| Volume: | 279,630 |
|---|
| Avg Vol (3m): | 397,527 |
|---|
| Market Cap: | 852.51M |
|---|
| P/E (ttm): | 19.70 |
|---|
| EPS (ttm): | 1.56 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- July Options Now Available For Bio-Reference Laboratories (BRLI)at TheStreet(Mon, May 20)
- Growth Stocks Portfolio That Can Outperform The Market By A Big Marginat Seeking Alpha(Mon, May 20)
- Outlook for the Most Shorted Stocksat Motley Fool(Fri, May 17)
- BioReference Laboratories, Inc to Speak at the UBS Global Healthcare ConferenceGlobeNewswire(Wed, May 15)
- BIO REFERENCE LABORATORIES INC Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Tue, May 14)
- BRLI Crosses Above Key Moving Average Levelat TheStreet(Fri, May 10)
- Super-Fast Growing Mid-Cap Growth Stocks With Explosive Returnsat Seeking Alpha(Fri, May 10)
- Bio-Reference Laboratories, Inc. to Speak at the Bank of America Merrill Lynch Health Care ConferenceGlobeNewswire(Wed, May 8)
- The Nasdaq's 5 Most Hated Stocksat Motley Fool(Fri, May 3)
- 7 Steps to Find Winning Stocksat Motley Fool(Thu, May 2)
- FDA Acting Faster in Areas of Unmet Medical Need: An Expert Analyst Discusses the Current Regulatory Environment with The Wall Street TranscriptWall Street Transcript(Fri, Apr 26)
- 10 Piotroski Stocks To Beat The Marketat Seeking Alpha(Fri, Apr 19)
- Bio-Reference Laboratories, Inc. Responds to an Employee Wrongful Termination Suit Filed Against it as Baseless and Without MeritGlobeNewswire(Fri, Apr 12)
- Why Bio-Reference Laboratories Is Dangerous Investmentat Seeking Alpha(Thu, Apr 11)
- Bio-Reference weakness attributed to circulation of whistleblower suitat theflyonthewall.com(Wed, Apr 10)
Key Statistics
| Forward P/E (1 yr): | 14.64 |
|---|
| P/S (ttm): | 1.26 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Oct-13)
: | 1.78 |
|---|
| Quarterly EPS Est
(Apr-13)
: | 0.41 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | 1.00 |
|---|
Business Summary
Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area.
View More